Hviid, Claus Vinter Bodker http://orcid.org/0000-0003-1740-7555
Lauridsen, Signe Voigt
Gyldenholm, Tua
Sunde, Niels
Parkner, Tina
Hvas, Anne-Mette
Funding for this research was provided by:
Fonden til Lægevidenskabens Fremme (17-L0027)
Region Midtjylland
Læge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat
Grosserer LF Foghts Fond (21.342)
Article History
Received: 1 October 2019
Revised: 12 November 2019
Accepted: 21 November 2019
First Online: 5 December 2019
Compliance with Ethical Standards
:
: The study was funded by “Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Legat”; “Grosserer L.F. Foghts Foundation (grant number 21.342),” and the AP Moller Foundation (grant number 17-L0027). CVBH received a scholarship from the Health Research Fund of Central Denmark Region.
: None of the authors have any conflicts of interest regarding the present paper but have the following general conflicts of interest: Anne-Mette Hvas has received a speaker’s fee from Astellas, CSL Behring, Bayer, Bristol-Myers Squibb, and Leo Pharma and unrestricted research support from Octapharma, CSL Behring, and Leo Pharma.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.The study was approved by the Regional Ethical Committee of Central Denmark Region (1–10–72-95-14, version 7, 02102017 and 1–10–72-94-14, version 7, 05102017) and the National Data Protection Agency (1–16–02-225-14 and 1–16–02-224-14).
: Written informed consent was obtained from all individual participants included in the study or from their legal representative.